Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Tracon Pharmaceuticals, Inc. (TCON)
Sector: Healthcare; Industry: Biotechnology

TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer and wet age-related macular degeneration (AMD). The company also develops TRC102, a small molecule that is in Phase II clinical trial for mesothelioma, Phase I clinical trial for solid tumors and lung cancer, and Phase I/II clinical trial for solid tumors and lymphomas; and TRC253, a small molecule high affinity competitive inhibitor of wild type androgen receptor (AR) and multiple AR mutant receptors that is in Phase I/II clinical trial for the treatment prostate cancer. The company has license agreements with Ambrx, Inc.; Santen Pharmaceutical Co. Ltd.; Roswell Park Cancer Institute and Health Research Inc.; Case Western Cancer Center; and Lonza Sales AG, as well as a cooperative research and development agreement with National Cancer Institute. TRACON Pharmaceuticals, Inc. was founded in 2004 and is headquartered in San Diego, California.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2016-11-29 MOTT DAVID M 10%-Owner Buy 869,565 $5.75 $4,999,999 No
2016-11-29 SANDELL SCOTT D 10%-Owner Buy 869,565 $5.75 $4,999,999 No
2016-11-29 Sonsini Peter W. 10%-Owner Buy 869,565 $5.75 $4,999,999 No
2016-11-29 Viswanathan Ravi 10%-Owner Buy 869,565 $5.75 $4,999,999 No
2016-11-29 New Enterprise Associates 14, L.P. 10%-Owner Buy 869,565 $5.75 $4,999,999 No
2016-06-03 SHAZER RONALD L Chief Medical Officer Sell 1,003 $7.48 $7,502 No
2015-10-16 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 1,500 $9.90 $14,848 No
2015-10-15 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 5,300 $10.16 $53,826 No
2015-10-13 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 3,168 $10.01 $31,711 No
2015-10-08 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 21,920 $10.10 $221,375 No
2015-10-05 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 15,100 $10.08 $152,256 No
2015-09-25 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 7,600 $12.13 $92,164 No
2015-09-24 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 22,303 $12.99 $289,746 No
2015-09-22 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 39,426 $14.02 $552,736 No
2015-09-18 LOGAN H CASEY Chief Business Officer Sell 5,000 $17.34 $86,700 Yes
2015-09-18 THEUER CHARLES President and CEO Sell 10,000 $17.34 $173,400 Yes
2015-09-17 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 42,344 $11.78 $498,928 No
2015-09-14 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 60,038 $11.78 $707,012 No
2015-09-10 THEUER CHARLES President and CEO Sell 3,516 $12.00 $42,192 No
2015-09-09 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 24,300 $10.59 $257,409 No
2015-09-03 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 15,300 $10.51 $160,839 No
2015-09-01 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 14,000 $10.42 $145,938 No
2015-08-24 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 3,000 $11.00 $33,000 No
2015-08-20 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 10,683 $11.36 $121,391 No
2015-08-18 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 11,174 $11.71 $130,811 No
2015-08-14 THEUER CHARLES President and CEO Sell 100 $12.00 $1,200 No
2015-08-13 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 9,361 $11.60 $108,571 No
2015-08-12 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 5,800 $11.40 $66,146 No
2015-08-10 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 8,300 $11.59 $96,209 No
2015-08-10 JAFCO Super V3 Investment Limited Partnership 10%-Owner Sell 8,300 $11.59 $96,209 No

Insider Smart

PROSPECT CAPITAL CORP (PSEC) - PSEC is the 2nd most bought stock of the past 90 days by insiders, CEO seems very confident about the company.

Insider Smart

Planet Fitness, Inc (PLNT) - Our position in PLNT is also inspired by insider trading, if insiders are comfortable and confident buying around $50, it is an easy hold if you can pick it up at an even lower price. Our avg cost of the position is ~$40 and is now with 50% profit.